Read + Share
Wohltmann WE. JAAD Game Changer: Inhibition of tumor necrosis factor improves conventional
steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a
cohort of patients. J Am Acad Dermatol 2024;90:1114.
PMID: 37717730
|
 |
|
